80 related articles for article (PubMed ID: 19527634)
1. [Characterization of endothelial progenitor cells and putative strategies to improve their expansion].
Smadja DM; Gaussem P
J Soc Biol; 2009; 203(2):197-207. PubMed ID: 19527634
[TBL] [Abstract][Full Text] [Related]
2. Endothelial progenitor cells: characterization, in vitro expansion, and prospects for autologous cell therapy.
Smadja DM; Cornet A; Emmerich J; Aiach M; Gaussem P
Cell Biol Toxicol; 2007 Jul; 23(4):223-39. PubMed ID: 17370127
[TBL] [Abstract][Full Text] [Related]
3. PAR-1 activation on human late endothelial progenitor cells enhances angiogenesis in vitro with upregulation of the SDF-1/CXCR4 system.
Smadja DM; Bièche I; Uzan G; Bompais H; Muller L; Boisson-Vidal C; Vidaud M; Aiach M; Gaussem P
Arterioscler Thromb Vasc Biol; 2005 Nov; 25(11):2321-7. PubMed ID: 16141404
[TBL] [Abstract][Full Text] [Related]
4. The angiopoietin pathway is modulated by PAR-1 activation on human endothelial progenitor cells.
Smadja DM; Laurendeau I; Avignon C; Vidaud M; Aiach M; Gaussem P
J Thromb Haemost; 2006 Sep; 4(9):2051-8. PubMed ID: 16803467
[TBL] [Abstract][Full Text] [Related]
5. Combination of stromal-derived factor-1alpha and vascular endothelial growth factor gene-modified endothelial progenitor cells is more effective for ischemic neovascularization.
Yu JX; Huang XF; Lv WM; Ye CS; Peng XZ; Zhang H; Xiao LB; Wang SM
J Vasc Surg; 2009 Sep; 50(3):608-16. PubMed ID: 19595531
[TBL] [Abstract][Full Text] [Related]
6. Bone morphogenetic proteins 2 and 4 are selectively expressed by late outgrowth endothelial progenitor cells and promote neoangiogenesis.
Smadja DM; Bièche I; Silvestre JS; Germain S; Cornet A; Laurendeau I; Duong-Van-Huyen JP; Emmerich J; Vidaud M; Aiach M; Gaussem P
Arterioscler Thromb Vasc Biol; 2008 Dec; 28(12):2137-43. PubMed ID: 18818419
[TBL] [Abstract][Full Text] [Related]
7. Impaired CXCR4 signaling contributes to the reduced neovascularization capacity of endothelial progenitor cells from patients with coronary artery disease.
Walter DH; Haendeler J; Reinhold J; Rochwalsky U; Seeger F; Honold J; Hoffmann J; Urbich C; Lehmann R; Arenzana-Seisdesdos F; Aicher A; Heeschen C; Fichtlscherer S; Zeiher AM; Dimmeler S
Circ Res; 2005 Nov; 97(11):1142-51. PubMed ID: 16254213
[TBL] [Abstract][Full Text] [Related]
8. Ex vivo priming of endothelial progenitor cells with SDF-1 before transplantation could increase their proangiogenic potential.
Zemani F; Silvestre JS; Fauvel-Lafeve F; Bruel A; Vilar J; Bieche I; Laurendeau I; Galy-Fauroux I; Fischer AM; Boisson-Vidal C
Arterioscler Thromb Vasc Biol; 2008 Apr; 28(4):644-50. PubMed ID: 18239152
[TBL] [Abstract][Full Text] [Related]
9. Interleukin 8 is differently expressed and modulated by PAR-1 activation in early and late endothelial progenitor cells.
Smadja DM; Bièche I; Susen S; Mauge L; Laurendeau I; d'Audigier C; Grelac F; Emmerich J; Aiach M; Gaussem P
J Cell Mol Med; 2009 Aug; 13(8B):2534-2546. PubMed ID: 18657231
[TBL] [Abstract][Full Text] [Related]
10. Prostaglandin E positively modulates endothelial progenitor cell homeostasis: an advanced treatment modality for autologous cell therapy.
Herrler T; Leicht SF; Huber S; Hermann PC; Schwarz TM; Kopp R; Heeschen C
J Vasc Res; 2009; 46(4):333-46. PubMed ID: 19142013
[TBL] [Abstract][Full Text] [Related]
11. Endothelial progenitor cells: characterization and role in vascular biology.
Urbich C; Dimmeler S
Circ Res; 2004 Aug; 95(4):343-53. PubMed ID: 15321944
[TBL] [Abstract][Full Text] [Related]
12. Plasma levels of stromal cell-derived factor-1 (CXCL12) and circulating endothelial progenitor cells in women with idiopathic heavy menstrual bleeding.
Elsheikh E; Andersson E; Sylvén C; Ericzon BG; Palmblad J; Mints M
Hum Reprod; 2014 Jan; 29(1):49-56. PubMed ID: 24218400
[TBL] [Abstract][Full Text] [Related]
13. Measuring angiogenic cytokines, circulating endothelial cells, and endothelial progenitor cells in peripheral blood and cord blood: VEGF and CXCL12 correlate with the number of circulating endothelial progenitor cells in peripheral blood.
Smythe J; Fox A; Fisher N; Frith E; Harris AL; Watt SM
Tissue Eng Part C Methods; 2008 Mar; 14(1):59-67. PubMed ID: 18454646
[TBL] [Abstract][Full Text] [Related]
14. The Rho kinase inhibitor fasudil augments the number of functional endothelial progenitor cells in ex vivo cultures.
O E; Ahn HY; Kim HK; You JC; Shin JC; Joe YA
Int J Mol Med; 2011 Sep; 28(3):357-63. PubMed ID: 21567077
[TBL] [Abstract][Full Text] [Related]
15. Efficient nonadhesive ex vivo expansion of early endothelial progenitor cells derived from CD34+ human cord blood fraction for effective therapeutic vascularization.
O E; Lee BH; Ahn HY; Shin JC; Kim HK; Kim M; Park IY; Park YG; Joe YA
FASEB J; 2011 Jan; 25(1):159-69. PubMed ID: 20852063
[TBL] [Abstract][Full Text] [Related]
16. Purification and long-term expansion of multipotent endothelial-like cells with potential cardiovascular regeneration.
Marchal JA; Picón M; Perán M; Bueno C; Jiménez-Navarro M; Carrillo E; Boulaiz H; Rodríguez N; Álvarez P; Menendez P; de Teresa E; Aránega A
Stem Cells Dev; 2012 Mar; 21(4):562-74. PubMed ID: 21542697
[TBL] [Abstract][Full Text] [Related]
17. Caveolin plays a central role in endothelial progenitor cell mobilization and homing in SDF-1-driven postischemic vasculogenesis.
Sbaa E; Dewever J; Martinive P; Bouzin C; Frérart F; Balligand JL; Dessy C; Feron O
Circ Res; 2006 May; 98(9):1219-27. PubMed ID: 16601228
[TBL] [Abstract][Full Text] [Related]
18. Stromal cell-derived factor 1alpha reduces senescence of endothelial progenitor subpopulation in lectin-binding and DiLDL-uptaking cell through telomerase activation and telomere elongation.
Zheng H; Shen CJ; Qiu FY; Zhao YB; Fu GS
J Cell Physiol; 2010 Jun; 223(3):757-63. PubMed ID: 20232301
[TBL] [Abstract][Full Text] [Related]
19. Differential activity of bone marrow hematopoietic stem cell subpopulations for EPC development and ischemic neovascularization.
Kwon SM; Lee YK; Yokoyama A; Jung SY; Masuda H; Kawamoto A; Lee YM; Asahara T
J Mol Cell Cardiol; 2011 Sep; 51(3):308-17. PubMed ID: 21557947
[TBL] [Abstract][Full Text] [Related]
20. Pretreatment of endothelial progenitor cells with osteopontin enhances cell therapy for peripheral vascular disease.
Vaughan EE; Liew A; Mashayekhi K; Dockery P; McDermott J; Kealy B; Flynn A; Duffy A; Coleman C; O'Regan A; Barry FP; O'Brien T
Cell Transplant; 2012; 21(6):1095-107. PubMed ID: 22304991
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
